ITRM20080214A1 - Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico. - Google Patents

Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.

Info

Publication number
ITRM20080214A1
ITRM20080214A1 IT000214A ITRM20080214A ITRM20080214A1 IT RM20080214 A1 ITRM20080214 A1 IT RM20080214A1 IT 000214 A IT000214 A IT 000214A IT RM20080214 A ITRM20080214 A IT RM20080214A IT RM20080214 A1 ITRM20080214 A1 IT RM20080214A1
Authority
IT
Italy
Prior art keywords
administrative
formulations
oral
derivatives
contain
Prior art date
Application number
IT000214A
Other languages
English (en)
Inventor
Canani Roberto Berni
Antonio Calignano
Orazio Mazzoni
Original Assignee
Uni Degli Studi Di Napoli Federico Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Di Napoli Federico Ii filed Critical Uni Degli Studi Di Napoli Federico Ii
Priority to IT000214A priority Critical patent/ITRM20080214A1/it
Priority to PL09734632T priority patent/PL2268605T3/pl
Priority to CN200980118019.3A priority patent/CN102105436B/zh
Priority to PCT/IT2009/000179 priority patent/WO2009130735A1/en
Priority to AU2009239330A priority patent/AU2009239330B2/en
Priority to ES09734632.4T priority patent/ES2498681T3/es
Priority to CA2721756A priority patent/CA2721756C/en
Priority to NZ589372A priority patent/NZ589372A/xx
Priority to DK09734632.4T priority patent/DK2268605T3/da
Priority to EP09734632.4A priority patent/EP2268605B1/en
Priority to RU2010147401/04A priority patent/RU2520070C2/ru
Priority to US12/988,556 priority patent/US9255062B2/en
Publication of ITRM20080214A1 publication Critical patent/ITRM20080214A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/31—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/90—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated
    • C07C233/91—Carboxylic acid amides having nitrogen atoms of carboxamide groups further acylated with carbon atoms of the carboxamide groups bound to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT000214A 2008-04-21 2008-04-21 Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico. ITRM20080214A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT000214A ITRM20080214A1 (it) 2008-04-21 2008-04-21 Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.
PL09734632T PL2268605T3 (pl) 2008-04-21 2009-04-21 Pochodne kwasów tłuszczowych do podawania doustnego obdarzone wysokimi walorami smakowymi
CN200980118019.3A CN102105436B (zh) 2008-04-21 2009-04-21 被赋予高适口性的口服脂肪酸衍生物
PCT/IT2009/000179 WO2009130735A1 (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability
AU2009239330A AU2009239330B2 (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability
ES09734632.4T ES2498681T3 (es) 2008-04-21 2009-04-21 Derivados de ácidos grasos con alta palatabilidad para administración oral
CA2721756A CA2721756C (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability
NZ589372A NZ589372A (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability
DK09734632.4T DK2268605T3 (da) 2008-04-21 2009-04-21 Fedtsyrederivater til oral indgivelse forsynet med høj palatabilitet
EP09734632.4A EP2268605B1 (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability
RU2010147401/04A RU2520070C2 (ru) 2008-04-21 2009-04-21 Производные жирных кислот для перорального введения, обеспечивающие высокие вкусовые качества
US12/988,556 US9255062B2 (en) 2008-04-21 2009-04-21 Fatty acid derivatives for oral administration endowed with high palatability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000214A ITRM20080214A1 (it) 2008-04-21 2008-04-21 Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.

Publications (1)

Publication Number Publication Date
ITRM20080214A1 true ITRM20080214A1 (it) 2009-10-22

Family

ID=40297237

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000214A ITRM20080214A1 (it) 2008-04-21 2008-04-21 Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.

Country Status (12)

Country Link
US (1) US9255062B2 (it)
EP (1) EP2268605B1 (it)
CN (1) CN102105436B (it)
AU (1) AU2009239330B2 (it)
CA (1) CA2721756C (it)
DK (1) DK2268605T3 (it)
ES (1) ES2498681T3 (it)
IT (1) ITRM20080214A1 (it)
NZ (1) NZ589372A (it)
PL (1) PL2268605T3 (it)
RU (1) RU2520070C2 (it)
WO (1) WO2009130735A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014172453A2 (en) * 2013-04-16 2014-10-23 Philadelphia Health And Education Corporation D/B/A Drexel University College Of Medicine Novel compositions useful in treating brain-related diseases or disorders and methods using same
SG11201803121WA (en) * 2015-11-09 2018-05-30 Mjn Us Holdings Llc Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
US20170127693A1 (en) * 2015-11-09 2017-05-11 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
EP3601245A1 (en) 2017-03-28 2020-02-05 The Regents of The University of Michigan Small molecule dcn1 inhibitors and therapeutic methods using the same
AU2019282691A1 (en) 2018-06-05 2020-12-24 Flagship Pioneering Innovations V, Inc. Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
JP2023548683A (ja) * 2020-11-18 2023-11-20 ディーエスエム アイピー アセッツ ビー．ブイ． Ｌ－フェニルアラニンブチルアミドの新規合成
IT202100009497A1 (it) 2021-04-15 2022-10-15 Rhea Innovations S R L Derivati amidici dell'acido butirrico come adiuvante nel trattamento e la prevenzione di infezione da sars-cov-2
CN113582871B (zh) * 2021-09-29 2022-01-04 北京天赋神奇科技有限公司 一种含镁水溶性欧米伽3脂肪酸

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3003898A1 (de) * 1980-02-02 1981-08-13 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur acylierung von aminocarbonsaeuren
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
RU2048807C1 (ru) * 1993-10-10 1995-11-27 Научно-исследовательская фирма "Ультрасан" Антибактериальный противовоспалительный препарат
US5880152A (en) * 1995-10-06 1999-03-09 Vertex Pharmaceuticals, Inc. Butyrate prodrugs derived from lactic acid
DE19629717C1 (de) * 1996-07-25 1998-02-12 Hoechst Ag Verfahren zur katalytischen Herstellung von N-Acylglycinderivaten
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US20060211603A1 (en) * 2004-08-18 2006-09-21 Vicuron Pharmaceuticals Inc. Ramoplanin derivatives possessing antibacterial activity

Also Published As

Publication number Publication date
NZ589372A (en) 2013-11-29
US9255062B2 (en) 2016-02-09
ES2498681T3 (es) 2014-09-25
EP2268605A1 (en) 2011-01-05
WO2009130735A8 (en) 2011-03-10
AU2009239330B2 (en) 2014-08-28
PL2268605T3 (pl) 2015-01-30
RU2010147401A (ru) 2012-05-27
US20110098319A1 (en) 2011-04-28
CN102105436B (zh) 2014-11-12
DK2268605T3 (da) 2014-09-15
WO2009130735A4 (en) 2010-01-21
CN102105436A (zh) 2011-06-22
EP2268605B1 (en) 2014-06-04
CA2721756A1 (en) 2009-10-29
CA2721756C (en) 2017-03-21
RU2520070C2 (ru) 2014-06-20
AU2009239330A1 (en) 2009-10-29
WO2009130735A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
ITRM20080214A1 (it) Derivati dell'acido butirrico somministrabili per via orale, formulazioni che li contengono e loro uso clinico.
CY2024007I2 (el) Γλυκοπυρανοζυλο-υποκατεστημενα παραγωγα βενζονιτριλιου, φαρμακευτικες συνθεσεις που περιεχουν τετοιες ενωσεις, η χρηση τους και μεθοδοι παρασκευης τους
ITMI20072416A1 (it) Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
HUE055911T2 (hu) Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására
EA201100969A1 (ru) Солевые формы органического соединения
BRPI0820681A2 (pt) formulações de ácido 3-(6-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilperidin-2-il)benzoico
SMT201500196B (it) Derivati dell'acido idrossammico
BRPI0812120A2 (pt) Formulação de nicotina oral revestida tamponada com aminoácido
BRPI0810439A2 (pt) Formulações farmacêuticas contendo derivados de ácido lipóico
IT1398643B1 (it) Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa
ATE483707T1 (de) 2-cyclopropylthiazolderivate
CY1116892T1 (el) Ενωσεις οι οποιες εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
EP2241304A4 (en) ORAL DENTAL COMPOSITION
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
IL235943A0 (en) Genistein salts, crystalline forms of same, compositions comprising same and uses thereof
CY1122596T1 (el) Νεες φαρμακοτεχνικες μορφες (τριμεθοξυφαινυλαμινο)πυριμιδινυλιου
FR2938192B1 (fr) Nouvel actif anti-vergetures et compositions le comprenant
BR112012016736A2 (pt) composição , formulação farmacêutica e uso da composição"
EP2196463A4 (en) PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, DERIVATIVES DERIVATED THEREOF AND PHARMACEUTICAL FORMULATIONS THEREOF
FR2939766B1 (fr) Pylone central d'aeronef.
HUE040484T2 (hu) Eljárás (3S,3S')4,4'-diszulfándiilbisz(3-aminobután-1-szulfonsav) elõállítására
ITFI20050041A1 (it) Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
BRPI0810962A2 (pt) Formulações de aminoácidos n-halogenados com compostos anti-inflamatórios